Furthermore, the tumor either presents a methylation profile aligned with subgroups pHGG RTK1, pHGG RTK2 or pHGG MYCN or it exhibits molecular features as PDGFRA alteration, EGFR alteration or MYCN amplification [1]. Here, MYCN is linked to neoplasm.